Hemorrhoidopexy. Third degree hemorrhoids
Conditions
Interventions
Intervention 1: Intervention group: Botox solution manufactured by Masoon Darou Company from Iran in an amount of 0.4 ml as an injection at the site of the operation. Intervention 2: Control group: Pl
Sponsors
Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients over 18 years of age Patients with symptomatic grade 3 or 4 hemorrhoids who are indicated for hemorrhoidectomy
Exclusion criteria
Exclusion criteria: Patients with inflammatory bowel disease Patients with fistula disease, Previous history of surgery in the anal area Patients with dermatitis, proctitis Patients with pregnancy-related illness Cardiovascular diseases Patients with severe respiratory illness Patients with cleft palate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity. Timepoint: It will be coded at 6 and 12 hours after surgery and again on days 1, 2, 7, and 14 after surgery. Pain will also be assessed after the first to fifth bowel movements. Method of measurement: Visual Analogue Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Wound healing quality. Timepoint: After surgery, five check-ups will be performed every two weeks from day 30 to 4 months after surgery. Method of measurement: Information collection form. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMina Alvandipour
Mazandaran University of Medical Sciences
Outcome results
None listed